Clinical trial
Diagnostic Study of Gene Alterations in Children Who Have Been Treated for…
NCT00003933 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003933 |
|---|---|
| Title | Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia |
| Official title | The Incidence and Prognostic Significance of P16 INK4A/ P15 INK4B Gene Alterations in Children With Relapsed ALL Treated on CCG-1941 |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Other |
| Interventions | laboratory biomarker analysis |
| Start date | Apr 1, 1999 |
| Primary completion | Apr 1, 2006 |
| First posted | May 2, 2003 |
| Last update posted | Aug 7, 2014 |
| Countries | Australia, Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: